SCHEMBL3846537

SCHEMBL3846537

CCOC(=O)c1ccc(-c2ncnc3ccc(Cl)cc23)cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMKK1 Q8N5S9 3/20 0.48
CAMKK2 Q96RR4 3/20 0.48
JAK3 P52333 6/20 0.47
JAK2 O60674 4/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPK10 P53779 1/20 0.47
MAPT P10636 1/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
NPC1 O15118 2/20 0.44
PDK1 Q15118 2/20 0.43
PKM P14618 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HTT P42858 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846925 0.93 JAK3 (0.48) CAMKK1CAMKK2JAK3JAK2MEN1
SCHEMBL3844913 0.83 PDK1 (0.50) CAMKK1CAMKK2PDK1PDK2PDK3
SCHEMBL14145475 0.78 MAP4K4 (0.50) JAK3JAK2PDK1PDK2PDK3
SCHEMBL7992264 0.77 MAPK1 (0.51) KMT2AKDM4ENPC1PKM
SCHEMBL3847833 0.77 DHODH (0.50) CAMKK1CAMKK2PDK1PDK2PDK3
SCHEMBL3846919 0.76 NPC1 (0.43) CAMKK1CAMKK2JAK3JAK2MAPT
SCHEMBL3846054 0.76 PDK1 (0.46) CAMKK1CAMKK2PDK1PDK2PDK3
SCHEMBL29681160 0.72 MEN1 (0.56) MEN1KMT2AMAPK10MAPTKDM4E
SCHEMBL29090950 0.72 MEN1 (0.56) MEN1KMT2AMAPK10MAPTKDM4E
SCHEMBL1367417 0.72 MEN1 (0.65) MEN1KMT2AMAPK10MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed